Catalyst Wire Dossier Catalyst Wire Dossier

Sapu003

· SAPU NANO (US) LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sapu003, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Sapu003 in Advanced mTOR-sensitive Solid Tumors [Phase 1]

See pricing